Anti-HBs characteristics after hepatitis B immunisation with plasma-derived and recombinant DNA-derived vaccines

By Heijtink R.A.   van Bergen P.   Paulij W.P.   de Man R.A.   Osterhaus A.D.M.E.  

Vaccine, Vol. 18, Iss. 15, 2000-02 ,pp. : 1531-1538

Elsevier

Access to resources Recommend Favorite

A follow-up study of combined vaccination with plasma-derived and recombinant hepatitis B vaccines in infants

By Ping-Ing L.   Chin-Yun L.   Li-Min H.   Jong-Min C.   Mei-Hwei C.  

Vaccine, Vol. 13, Iss. 17, 1995-12 ,pp. : 1685-1689

Elsevier

Access to resources Recommend Favorite

Antibody responses to recombinant hepatitis B vaccines

By Hessel L.   West D.J.  

Vaccine, Vol. 20, Iss. 17, 2002-05 ,pp. : 2164-2165

Elsevier

Access to resources Recommend Favorite

Two different dosages of yeast derived recombinant hepatitis B vaccines: a comparison of immunogenicity

By Chiaramonte M.   Majori S.   Ngatchu T.   Moschen M.E.   Baldo V.   Renzulli G.   Simoncello I.   Rocco S.   Bertin T.   Naccarato R.   Trivello R.  

Vaccine, Vol. 14, Iss. 2, 1996-02 ,pp. : 135-137

Elsevier

Access to resources Recommend Favorite

Newborn universal immunisation against hepatitis B: immunogenicity and reactogenicity of simultaneous administration of diphtheria/tetanus/pertussis (DTP) and oral polio vaccines with hepatitis B vaccine at 0, 2 and 6 months of age

By Aristegui J.   Muniz J.   Legorburu A.P.   Imaz M.   Arrate J.P.   Suarez M.D.   Goiri M.D.  

Vaccine, Vol. 13, Iss. 11, 1995-01 ,pp. : 973-977

Elsevier

Access to resources Recommend Favorite